ANG1005 in Patients With Recurrent High-Grade Glioma

NCT01967810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma
Glioblastoma
Brain Tumor, Recurrent

Interventions

DRUG: ANG1005
DRUG: Bevacizumab

Sponsor

Angiochem Inc